Cover Image
Market Research Report
Product code
991912

Global Sinusitis Drugs Market 2021-2025

Published: | TechNavio (Infiniti Research Ltd.) | 120 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Sinusitis Drugs Market 2021-2025
Published: February 25, 2021
TechNavio (Infiniti Research Ltd.)
Content info: 120 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

Technavio has been monitoring the sinusitis drugs market and it is poised to grow by $ 466.44 mn during 2021-2025, progressing at a CAGR of 4% during the forecast period. Our report on sinusitis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of sinusitis, growing awareness among people about sinusitis treatment and increasing mergers and acquisitions. In addition, rising prevalence of sinusitis is anticipated to boost the growth of the market as well.

The sinusitis drugs market analysis includes product segment and geographical landscapes.

Technavio's sinusitis drugs market is segmented as below:

By Product

  • Steroid nasal sprays
  • Antibiotics
  • Decongestants
  • Other drugs

By Geographical Landscapes

  • North America
  • Europe
  • Asia
  • ROW

This study identifies advent of biologics as one of the prime reasons driving the sinusitis drugs market growth during the next few years. Also, increasing investments in R&D by major players and technological advances will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on sinusitis drugs market covers the following areas:

  • Sinusitis drugs market sizing
  • Sinusitis drugs market forecast
  • Sinusitis drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sinusitis drugs market vendors that include AbbVie Inc., Bayer AG, GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Johnson & Johnson, Merck & Co. Inc., Neopharma Corp., Pfizer Inc., Sanofi SA, and Sun Pharmaceutical Industries Ltd. Also, the sinusitis drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents
Product Code: IRTNTR70260

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Steroid nasal sprays - Market size and forecast 2020-2025
  • Antibiotics - Market size and forecast 2020-2025
  • Decongestants - Market size and forecast 2020-2025
  • Other drugs - Market size and forecast 2020-2025
  • Market opportunity by Product

Customer Landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Bayer AG
  • GlaxoSmithKline Plc
  • Hikma Pharmaceuticals Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Neopharma Corp.
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

1: Key Finding 1

2: Key Finding 2

3: Key Finding 3

4: Key Finding 5

5: Key Finding 6

6: Key Finding 7

7: Key Finding 8

8: Parent market

9: Market characteristics

10: Offerings of vendors included in the market definition

11: Market segments

12: Global - Market size and forecast 2020 - 2025 ($ million)

13: Global market: Year-over-year growth 2020 - 2025 (%)

14: Five forces analysis 2020 & 2025

15: Bargaining power of buyers

16: Bargaining power of suppliers

17: Threat of new entrants

18: Threat of substitutes

19: Threat of rivalry

20: Market condition - Five forces 2020

21: Product - Market share 2020-2025 (%)

22: Comparison by Product

23: Steroid nasal sprays - Market size and forecast 2020-2025 ($ million)

24: Steroid nasal sprays - Year-over-year growth 2020-2025 (%)

25: Antibiotics - Market size and forecast 2020-2025 ($ million)

26: Antibiotics - Year-over-year growth 2020-2025 (%)

27: Decongestants - Market size and forecast 2020-2025 ($ million)

28: Decongestants - Year-over-year growth 2020-2025 (%)

29: Other drugs - Market size and forecast 2020-2025 ($ million)

30: Other drugs - Year-over-year growth 2020-2025 (%)

31: Market opportunity by Product

32: Customer landscape

33: Market share by geography 2020-2025 (%)

34: Geographic comparison

35: North America - Market size and forecast 2020-2025 ($ million)

36: North America - Year-over-year growth 2020-2025 (%)

37: Europe - Market size and forecast 2020-2025 ($ million)

38: Europe - Year-over-year growth 2020-2025 (%)

39: Asia - Market size and forecast 2020-2025 ($ million)

40: Asia - Year-over-year growth 2020-2025 (%)

41: ROW - Market size and forecast 2020-2025 ($ million)

42: ROW - Year-over-year growth 2020-2025 (%)

43: Key leading countries

44: Market opportunity by geography ($ million)

45: Impact of drivers and challenges

46: Vendor landscape

47: Landscape disruption

48: Industry risks

49: Vendors covered

50: Market positioning of vendors

51: AbbVie Inc. - Overview

52: AbbVie Inc. - Business segments

53: AbbVie Inc. - Key offerings

54: AbbVie Inc. - Key customers

55: AbbVie Inc. - Segment focus

56: Bayer AG - Overview

57: Bayer AG - Business segments

58: Bayer AG - Key offerings

59: Bayer AG - Key customers

60: Bayer AG - Segment focus

61: GlaxoSmithKline Plc - Overview

62: GlaxoSmithKline Plc - Business segments

63: GlaxoSmithKline Plc - Key offerings

64: GlaxoSmithKline Plc - Key customers

65: GlaxoSmithKline Plc - Segment focus

66: Hikma Pharmaceuticals Plc - Overview

67: Hikma Pharmaceuticals Plc - Business segments

68: Hikma Pharmaceuticals Plc - Key offerings

69: Hikma Pharmaceuticals Plc - Key customers

70: Hikma Pharmaceuticals Plc - Segment focus

71: Johnson & Johnson - Overview

72: Johnson & Johnson - Business segments

73: Johnson & Johnson - Key offerings

74: Johnson & Johnson - Key customers

75: Johnson & Johnson - Segment focus

76: Merck & Co. Inc. - Overview

77: Merck & Co. Inc. - Business segments

78: Merck & Co. Inc. - Key offerings

79: Merck & Co. Inc. - Key customers

80: Merck & Co. Inc. - Segment focus

81: Neopharma Corp. - Overview

82: Neopharma Corp. - Product and service

83: Neopharma Corp. - Key offerings

84: Neopharma Corp. - Key customers

85: Neopharma Corp. - Segment focus

86: Pfizer Inc. - Overview

87: Pfizer Inc. - Business segments

88: Pfizer Inc. - Key offerings

89: Pfizer Inc. - Key customers

90: Pfizer Inc. - Segment focus

91: Sanofi SA - Overview

92: Sanofi SA - Business segments

93: Sanofi SA - Key offerings

94: Sanofi SA - Key customers

95: Sanofi SA - Segment focus

96: Sun Pharmaceutical Industries Ltd. - Overview

97: Sun Pharmaceutical Industries Ltd. - Business segments

98: Sun Pharmaceutical Industries Ltd. - Key offerings

99: Sun Pharmaceutical Industries Ltd. - Key customers

100: Sun Pharmaceutical Industries Ltd. - Segment focus

101: Currency conversion rates for US$

102: Research Methodology

103: Validation techniques employed for market sizing

104: Information sources

105: List of abbreviations